Margaret Mulligan

Overview 2010 2009 2008

2010

In 2010, Margaret Mulligan earned a total compensation of $6.7M as Executive Vice, President, Chief Financial Officer at Valeant Pharmaceuticals International, a 276% increase compared to previous year.

Compensation breakdown

Option Awards	$1,394,250
Salary	$472,917
Stock Awards	$1,429,938
Other	$3,400,435
Total	$6,697,540

Mulligan received $3.4M in other compensation, accounting for 51% of the total pay in 2010.

Mulligan also received $1.4M in option awards, $472.9K in salary and $1.4M in stock awards.

Rankings

In 2010, Margaret Mulligan's compensation ranked 645th out of 10,439 executives tracked by ExecPay. In other words, Mulligan earned more than 93.8% of executives.

Classification	Ranking	Percentile
All	645 out of 10,439	94th
Division Manufacturing	225 out of 3,838	94th
Major group Chemicals And Allied Products	54 out of 921	94th
Industry group Drugs	33 out of 680	95th
Industry Pharmaceutical Preparations	28 out of 481	94th

Source: SEC filing on April 14, 2011.

Overview 2009

Mulligan's colleagues

We found eight more compensation records of executives who worked with Margaret Mulligan at Valeant Pharmaceuticals International in 2010.